122 results
Page 4 of 7
8-K
EX-99.1
rpam12ufie
27 Oct 20
Sobi obtains global co-development and exclusive ex-U.S. commercialization rights for systemic pegcetacoplan, a targeted C3 therapy
7:17am
8-K
3m64oog18f1w5f9471y
27 Oct 20
Sobi obtains global co-development and exclusive ex-U.S. commercialization rights for systemic pegcetacoplan, a targeted C3 therapy
7:17am
8-K
EX-10.1
9o12h
7 May 20
Apellis Pharmaceuticals Announces Private Placement of Convertible Senior Notes
7:44am
8-K
EX-1.1
mvw kzd4no
9 Jan 20
Apellis Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5:22pm
S-3ASR
EX-4.3
7inucb2
7 Jan 20
Automatic shelf registration
4:01pm
S-3ASR
EX-4.4
xbaphutp0oz o8qu
7 Jan 20
Automatic shelf registration
4:01pm